The overexpression of BAZ1B, and therefore that of SMARCA5, could potentiate the function of TOP1 during DNA replication, affecting the response of cancer cells to TOP1 inhibitors and to other treatments affecting replication [51]. Here, SMARCA5 is linked to cancer.